Posts

Showing posts with the label expecting earnings

Stocks making the biggest moves after hours: H.B. Fuller, KB Home, Lennar and more

Residential single family homes construction by KB Home Residential single family homes construction by KB Home are shown under construction in the community of Valley Center, California, U.S. June 3, 2021. Mike Blake | Reuters Check out the companies making headlines after hours. KB Home — Shares dipped 21% in extended trading after the homebuilder disappointed on revenue expectations in its earnings results. KB Home reported earnings of $2.86 per share on revenue of $1.85 billion. Analysts surveyed by Refinitiv were expecting earnings of $2.67 per share on revenue of $1.87 billion. Steelcase — The furniture stock declined 0.4% after Steelcase reported quarterly results that missed on revenue estimates. The company reported earnings of 21 cents per share on revenue of $863.3 million. Analysts were expecting earnings of 12 cents per share on revenue of $884.1 million, according to consensus estimates from FactSet. H.B. Fuller Company — The adhesive manufacturing company jumped 4.9% a...

Stocks making the biggest moves midday: Zscaler, DocuSign, Virgin Galactic, Kroger and more

In this article REGN RH TSLA CAT The Kroger supermarket chain's headquarters is shown in Cincinnati, Ohio. Lisa Baertlein | Reuters Check out the companies making headlines in midday trading Friday. Zscaler — Zscaler surged 20% after reporting strong earnings in its most recent quarter. The company posted adjusted earnings of 25 cents per share on $318 million in revenue. Analysts surveyed by Refinitiv were expecting earnings of 20 cents per share on revenues of $305 million. DocuSign — Shares jumped 9.9% after the electronic agreement company&#x27 ;s quarterly numbers topped analyst expectations. DocuSign's revenue guidance for the third quarter was also above expectations, and its full-year outlook was in line with estimates. Regeneron Pharmaceuticals — The pharmaceutical stock gained 3.5% after Morgan Stanley upgraded shares to overweight from equal weight following the release of positive results from its eye drug trial. Regeneron soared nearly 19% the prior day on th...